How IR Pellets Improve Drug Absorption and Fast Release in Medicines

What Are IR Pellets? A Quick Recap

Immediate-release pellets are small, spherical or near-spherical pharmaceutical units — typically 500 to 1500 micrometres (µm) in diameter — loaded with one or more APIs and designed to release the drug rapidly upon contact with gastrointestinal fluids. Unlike sustained-release or enteric-coated pellets, IR pellets carry no rate-controlling polymer membrane. Their design goal is speed: get the drug into solution as fast as possible so that absorption can begin immediately.

IR pellets are typically filled into hard gelatin or HPMC capsules, compressed into MUPS (multiple unit pellet system) tablets, or packaged in sachets for reconstitution as dry syrups. Once administered, they disperse throughout the gastrointestinal tract as individual units — a distribution that fundamentally changes how the drug is absorbed compared to a single large tablet.

The Science of Drug Absorption: Why Dosage Form Matters

Step 1: Disintegration and Dissolution

Drug absorption from an oral solid dosage form begins with two essential preliminary steps: disintegration (the breaking apart of the dosage unit) and dissolution (the dissolving of the drug into gastrointestinal fluid). Both steps must occur before any absorption is possible.

A conventional tablet must first disintegrate — a process that can be delayed by slow tablet wetting, poor disintegrant performance, or incomplete tablet erosion. The resulting granule or particle fragments must then dissolve — a process governed by particle size, surface area, and drug solubility.

IR pellets circumvent many of these delays. Because pellets are already in a small, discrete unit form when the capsule dissolves, they immediately present a large, distributed surface area to gastrointestinal fluid — accelerating dissolution and eliminating the disintegration delay of a conventional tablet.

Step 2: Gastrointestinal Distribution

Step 3: Membrane Permeation and Systemic Uptake

Once drug molecules are dissolved in gastrointestinal fluid, they must permeate the intestinal epithelial membrane to enter the systemic circulation. For BCS Class I drugs (high solubility, high permeability), the dissolution step governs absorption speed. For BCS Class II drugs (low solubility, high permeability), the dissolution step is the rate-limiting factor — and this is where IR pellet formulation design can make a transformative difference.

How IR Pellet Formulation Enhances Drug Absorption

1. Particle Size Engineering for Dissolution Enhancement

The dissolution rate of a drug particle is governed by the Noyes-Whitney equation, which states that dissolution rate is proportional to the surface area of the dissolving particle. Reducing particle size dramatically increases surface area and therefore dissolution rate. In extrusion-spheronisation, the API is reduced to micron-scale particles before granulation — creating IR pellets with a far higher surface area:volume ratio than conventional tablet granules.

For poorly water-soluble drugs, Credo Life Sciences employs micronisation of the API to a D50 of 3–10 µm before granulation, achieving 3–5× improvement in dissolution rate compared to unmicronised drug. This approach is particularly valuable for BCS Class II APIs including fenofibrate, ibuprofen, indomethacin, and similar lipophilic molecules.

2. Solid Dispersion IR Pellets for BCS Class II/IV Drugs

For drugs with both low solubility and complex crystalline structure, solid dispersion technology disperses the API at the molecular level within a hydrophilic polymer matrix — effectively converting the drug from a crystalline to an amorphous form, dramatically increasing apparent solubility.

Credo Life Sciences manufactures solid dispersion IR pellets using hot-melt extrusion (HME) and spray-drying-followed-by-spheronisation approaches. Polymers including PVP, HPMC-AS, and Soluplus are used as amorphous stabilisers. Solid dispersion IR pellets can achieve 10–50× improvement in dissolution for challenging BCS Class II and IV drugs.

3. Surfactant-Assisted Wetting

Some APIs are inherently hydrophobic — they resist wetting by aqueous gastrointestinal fluids, creating a dissolution barrier even after disintegration. IR pellet formulations incorporating pharmaceutical-grade surfactants (sodium lauryl sulphate, polysorbate 80, d-alpha tocopheryl polyethylene glycol 1000 succinate) directly into the pellet matrix promote rapid wetting and improve drug dissolution.

4. MCC-Based Pellet Cores for Maximum Porosity

Microcrystalline cellulose (MCC) is the excipient of choice for extrusion-spheronisation-based IR pellets. MCC's unique water-absorbing and plastic deformation properties produce pellets with a highly porous internal matrix. This porosity allows gastrointestinal fluid to rapidly penetrate the pellet core, dissolving the drug from within as well as from the surface — dramatically accelerating dissolution compared to dense tablet matrices.

Clinical Scenarios Where IR Pellets Offer Distinct Advantages

Paediatric Medicine — Sprinkle Capsules

Children who cannot swallow tablets or capsules can have sprinkle capsule contents — IR pellets — opened and sprinkled onto soft food such as yoghurt, applesauce, or fruit puree. The individual pellets are small enough to be swallowed with food without difficulty, while the IR formulation ensures that the drug is absorbed as rapidly as from a conventional oral dose.

Credo Life Sciences manufactures IR pellets in sprinkle capsule-compatible formats for paediatric antibiotic, antiepileptic, and PPI applications.

Combination Products

IR pellets can be combined with SR or EC pellets of the same or different drugs in a single capsule — creating combination products with precisely designed pharmacokinetic profiles. For example, an IR pellet loading dose combined with SR pellets for prolonged therapeutic levels, all in a single once-daily capsule.

Drugs Requiring Rapid Onset

For analgesics, antipyretics, anti-emetics, and anti-allergics where the speed of therapeutic onset is the primary patient requirement, IR pellets' faster and more consistent dissolution versus tablets translates directly to faster symptom relief and improved patient satisfaction.

Quality Standards for IR Pellets at Credo Life Sciences